INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2013

Yeast beta-glucan supplementation reduced symptomatic common cold infections by 25% in healthy participants with recurring infections.

In a double-blind, randomized, multicentric trial, 162 healthy participants with recurring infections took 900 mg daily of either placebo (n = 81) or an insoluble brewers' yeast (1,3)-(1,6)-beta-D-glucan preparation (n = 81) for 16 weeks. In the per-protocol population, yeast beta-glucan reduced symptomatic common cold infections by 25% compared to placebo (p = 0.041). The mean symptom score was 15% lower with beta-glucan (p = 0.125), and beta-glucan significantly reduced sleep difficulties caused by cold episodes (p = 0.028). Efficacy was rated better for beta-glucan than placebo by both physicians (p = 0.004) and participants (p = 0.012).

Study type
Double-blind, randomized, placebo-controlled, multicentric trial
Who was studied
162 healthy participants with recurring infections
What was measured
Number of common cold episodes, infection symptom scores, sleep difficulties, and efficacy ratings

THE PAPER

Yeast (1,3)-(1,6)-beta-glucan helps to maintain the body's defence against pathogens: a double-blind, randomized, placebo-controlled, multicentric study in healthy subjects.

Auinger A, Riede L, Bothe G, Busch R, Gruenwald J. Eur J Nutr, 2013.

PubMed 23340963 ↗DOI 10.1007/s00394-013-0492-z ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.